Abstract

*O. Benzerouale, C. Abdi, S. Lkhoyaali, S. Boutayeb and H. Errihani

ABSTRACT

Introduction: cancer is a major cause of death worldwide, and its treatment requires a multidisciplinary approach based on evidence-based medicine. Recently, there has been growing interest in real-world data. These health data, collected outside controlled clinical trials, reflect the real population and provide concrete evidence (RWE). Real world data (RWD) is clinical evidence based on data collected in real-life practice. They are used by health authorities to assess the safety of health products. Increasingly integrated into oncology clinical research, RWD is seen as an alternative source of evidence to guide the decisions of regulators, payers and clinicians. However, their quality can be limited, requiring an approach that combines the strengths of randomized controlled trials and RWD studies. In Morocco, specific challenges exist for the collection and use of real data in oncology, requiring efforts to build research capacity. RWD enables resource-limited countries to conduct real-life studies and contribute to research by improving cancer management.